Fact CheckerSign in

NCT06683573Completed

Health Literacy 3D Kidney Model Patient Education Trial

Optimizing Health Literacy and Disease Management Through 3D Kidney Model: Innovative Patient Education Approaches for Underserved Patients Impacted by Social Determinants of Health

Source: ClinicalTrials.gov · Last updated 21 May 2025

Brief summary (registry, in English)

High blood pressure has a different rate effect on many minoritized individuals. African Americans, as a result of high blood pressure, are six times more likely to go through kidney failure compared to white counterparts. Hispanic communities are also disproportionately affected by high blood pressure and, unfortunately, generally have lower knowledge about the effects on the kidneys as well. Unfortunately, many minoritized and underserved communities are affected by the weight of the social determinants of health, i.e., housing, education, food, health care, etc., that contribute to large disparities in health outcomes. These factors lead to poor care management, less ability to manage care effectively, and disengagement from care. Health education is vital to recognizing and communicating with minoritized patients with hypertension-induced chronic renal disease. As the patient's knowledge of the condition grows, this can significantly influence the trust between clinicians and patients. Effective and patient-centered education can inspire patients to be proactive in their prevention strategies with clinicians. This study's overall goal is to assess the utility of a novel patient education tool (3D-printed healthy kidney and diseased kidney models) in optimizing patient education for underserved populations who have hypertension with a potential lead to hypertension-induced chronic renal disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
35 (actual)
First submitted
8 Nov 2024
Start date
25 Feb 2025
Primary completion date
27 Mar 2025
Lead sponsor
Hilary L Surratt, PhD
NCT number
NCT06683573

What you commit to

  • Study type: Interventional
  • Participants enrolled: 35
  • From 25 Feb 2025 to the primary completion date, 27 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Ages 18 and older
  • Seeking medical care in study location
  • Current diagnosis of hypertension and renal disease

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kentucky
Coordinator of this site? Confirm its status
LexingtonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.